Director Jan De Witte filed a Form 4 with the SEC on November 12, 2026, reporting the disposition of 59.981 shares of ResMed Inc. common stock on November 11, 2026, to cover tax withholding obligations upon the vesting of restricted stock units.
Key Highlights
- Reporting person: Jan De Witte, identified as a director of ResMed Inc. (NYSE:RMD)
- Transaction date: November 11, 2026, with the form signed and filed on November 12, 2026
- Shares disposed: 59.981 shares of ResMed Common Stock, surrendered to the issuer for tax withholding
- Price per share: $234.11, as stated in the filing
- Transaction code: F, indicating a disposition to the issuer for tax withholding on vesting of restricted stock units
- RSU grant date: The underlying restricted stock units were granted on November 20, 2025, according to the filing
- Remaining beneficial ownership: 4,201 shares of ResMed Common Stock held directly following the transaction
De Witte RSU Tax Withholding Transaction on November 11, 2026
According to the filing, Jan De Witte, a director of ResMed Inc. (NYSE:RMD), disposed of 59.981 shares of ResMed Common Stock on November 11, 2026, at a price of $234.11 per share. The transaction carried transaction code F, which the filing explains as a "Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/20/2025."
The shares were disposed of directly and are recorded in Table I of the Form 4 as non-derivative securities. No derivative securities transactions were reported in Table II. Following this transaction, the filing states that De Witte directly holds 4,201 shares of ResMed Common Stock.
The form was filed individually by one reporting person and does not indicate that the transaction was made pursuant to a Rule 10b5-1(c) trading plan, as the corresponding checkbox on the form was not checked. De Witte's address is listed as c/o ResMed Inc., 9001 Spectrum Center Blvd., San Diego, California 92123.
What Was Disclosed
The filing reports a single transaction by ResMed director Jan De Witte: the surrender of 59.981 shares at $234.11 per share to the issuer for tax withholding upon the vesting of restricted stock units originally granted on November 20, 2025, leaving a direct holding of 4,201 shares.




Please wait processing your request...